CA
RXRX icon

Clearstead Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Clearstead Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,479
Closed -$6.05K – 2751
2025
Q4 		$6.05K Buy
+1,479
New +$7.33K ﹤0.01% 1985
2025
Q3 		– Hold
0
– – – 3225
2025
Q2 		– Hold
0
– – – 2863
2025
Q1 		– Hold
0
– – – 2302
2024
Q4 		– Hold
0
– – – 2180
2024
Q3 		– Sell
-125
Closed -$896 – 2103
2024
Q2 		$938 Sell
125
-100
-44% -$872 ﹤0.01% 1902
2024
Q1 		$2.13K Buy
225
+100
+80% +$1.11K ﹤0.01% 1301
2023
Q4 		$1.23K Sell
125
-125
-50% -$891 ﹤0.01% 1374
2023
Q3 		$1.91K Buy
+250
New +$2.49K ﹤0.01% 1409

Other funds holding RXRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return